Works matching Designer drugs
Results: 1225
The European Arrest Warrant in Designer Drugs Cases. With or Without Verification of Double Criminality?
- Published in:
- European Journal on Criminal Policy & Research, 2023, v. 29, n. 2, p. 247, doi. 10.1007/s10610-021-09487-2
- By:
- Publication type:
- Article
Comparison of LC-MS and LC-DAD Methods of Detecting Abused Piperazine Designer Drugs.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 7, p. 1758, doi. 10.3390/jcm11071758
- By:
- Publication type:
- Article
Rapid Targeted Method of Detecting Abused Piperazine Designer Drugs.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 24, p. 5813, doi. 10.3390/jcm10245813
- By:
- Publication type:
- Article
Laser Lights and Designer Drugs: New Techniques for Descending Levels of Mechanisms "in a Single Bound"?
- Published in:
- Topics in Cognitive Science, 2020, v. 12, n. 4, p. 1241, doi. 10.1111/tops.12452
- By:
- Publication type:
- Article
Construction of pioneering quantitative structure activity relationship screening models for abuse potential of designer drugs using index of ideality of correlation in monte carlo optimization.
- Published in:
- Archives of Toxicology, 2020, v. 94, n. 9, p. 3069, doi. 10.1007/s00204-020-02828-w
- By:
- Publication type:
- Article
Designer drugs: mechanism of action and adverse effects.
- Published in:
- Archives of Toxicology, 2020, v. 94, n. 4, p. 1085, doi. 10.1007/s00204-020-02693-7
- By:
- Publication type:
- Article
Piperazine designer drugs elicit toxicity in the alternative in vivo model Caenorhabditis elegans.
- Published in:
- Journal of Applied Toxicology, 2020, v. 40, n. 3, p. 363, doi. 10.1002/jat.3909
- By:
- Publication type:
- Article
In vitro neurotoxicity evaluation of piperazine designer drugs in differentiated human neuroblastoma SH-SY5Y cells.
- Published in:
- Journal of Applied Toxicology, 2016, v. 36, n. 1, p. 121, doi. 10.1002/jat.3153
- By:
- Publication type:
- Article
Determination of 32 cathinone derivatives and other designer drugs in serum by comprehensive LC-QQQ-MS/MS analysis.
- Published in:
- Analytical & Bioanalytical Chemistry, 2013, v. 405, n. 4, p. 1383, doi. 10.1007/s00216-012-6548-8
- By:
- Publication type:
- Article
Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography–mass spectrometry.
- Published in:
- Analytical & Bioanalytical Chemistry, 2010, v. 397, n. 3, p. 1225, doi. 10.1007/s00216-010-3636-5
- By:
- Publication type:
- Article
Clinical features of patients with designer-drug-related disorder in Japan: A comparison with patients with methamphetamine- and hypnotic/anxiolytic-related disorders.
- Published in:
- Psychiatry & Clinical Neurosciences, 2014, v. 68, n. 5, p. 374, doi. 10.1111/pcn.12140
- By:
- Publication type:
- Article
Study on the Analysis and Synthesis of Designer Drugs, Piperazine.
- Published in:
- Indian Journal of Forensic Medicine & Toxicology, 2019, v. 13, n. 2, p. 125, doi. 10.5958/0973-9130.2019.00098.7
- By:
- Publication type:
- Article
Designer drugs 2015: assessment and management.
- Published in:
- Addiction Science & Clinical Practice, 2015, v. 10, n. 1, p. 1, doi. 10.1186/s13722-015-0024-7
- By:
- Publication type:
- Article
Complex evaluation of Raman spectra using morphological filtering: Algorithms, software implementation, and experimental verification of baseline correction, peak recognition, and cosmic ray removal in SERS spectra of designer drugs.
- Published in:
- Journal of Raman Spectroscopy, 2022, v. 53, n. 12, p. 2100, doi. 10.1002/jrs.6448
- By:
- Publication type:
- Article
‘Designer drugs': update on the management of novel psychoactive substance misuse in the acute care setting.
- Published in:
- Clinical Medicine, 2014, v. 14, n. 4, p. 409, doi. 10.7861/clinmedicine.14-4-409
- By:
- Publication type:
- Article
Designer Drugs: An Emerging Challenge in Substance-Induced Disorders.
- Published in:
- Journal of Rehabilitation, 2020, v. 86, n. 2, p. 4
- By:
- Publication type:
- Article
Death Following Recreational Use of Designer Drug 'Bath Salts' Containing 3,4-Methylenedioxypyrovalerone (MDPV).
- Published in:
- Journal of Medical Toxicology, 2012, v. 8, n. 1, p. 69, doi. 10.1007/s13181-011-0196-9
- By:
- Publication type:
- Article
New Synthetic Cannabinoid - Methyl 2-{[1-(5-Fluoro-Pentyl)-3-Methyl-1 H-Indol-3-Ylcarbonyl]-Amino}Butyrate - as a Designer Drug.
- Published in:
- Chemistry of Heterocyclic Compounds, 2014, v. 50, n. 4, p. 583, doi. 10.1007/s10593-014-1511-6
- By:
- Publication type:
- Article
Studies on the phase I metabolism of the new designer drug 3-fluoromethcathinone using rabbit liver slices.
- Published in:
- International Journal of Legal Medicine, 2012, v. 126, n. 2, p. 231, doi. 10.1007/s00414-011-0601-6
- By:
- Publication type:
- Article
In vitro cytochrome P450 inhibition potential of methylenedioxy-derived designer drugs studied with a two-cocktail approach.
- Published in:
- Archives of Toxicology, 2016, v. 90, n. 2, p. 305, doi. 10.1007/s00204-014-1412-6
- By:
- Publication type:
- Article
Metabolism and toxicological detection of the designer drug 4-chloro-2,5-dimethoxyamphetamine in rat urine using gas chromatography-mass spectrometry.
- Published in:
- Analytical & Bioanalytical Chemistry, 2008, v. 390, n. 7, p. 1837, doi. 10.1007/s00216-008-1917-z
- By:
- Publication type:
- Article
The Designer Drug 3-Fluoromethcathinone Induces Oxidative Stress and Activates Autophagy in HT22 Neuronal Cells.
- Published in:
- Neurotoxicity Research, 2018, v. 34, n. 3, p. 388, doi. 10.1007/s12640-018-9898-y
- By:
- Publication type:
- Article
Identification of three new phase II metabolites of a designer drug methylone formed in rats by N-demethylation followed by conjugation with dicarboxylic acids.
- Published in:
- Xenobiotica, 2018, v. 48, n. 6, p. 618, doi. 10.1080/00498254.2017.1349964
- By:
- Publication type:
- Article
Differential responses to anticipation of reward after an acute dose of the designer drugs benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) alone and in combination using functional magnetic resonance imaging (fMRI).
- Published in:
- Psychopharmacology, 2013, v. 229, n. 4, p. 673, doi. 10.1007/s00213-013-3128-3
- By:
- Publication type:
- Article
Metabolic fate, mass spectral fragmentation, detectability, and differentiation in urine of the benzofuran designer drugs 6-APB and 6-MAPB in comparison to their 5-isomers using GC-MS and LC-(HR)-MS techniques.
- Published in:
- Analytical & Bioanalytical Chemistry, 2015, v. 407, n. 12, p. 3457, doi. 10.1007/s00216-015-8552-2
- By:
- Publication type:
- Article
NBOMe Designer Drug Exposures Reported to Texas Poison Centers.
- Published in:
- Journal of Addictive Diseases, 2014, v. 33, n. 3, p. 196, doi. 10.1080/10550887.2014.950027
- By:
- Publication type:
- Article
New Opportunities for the Utilization of the Sulfoximine Group in Medicinal Chemistry from the Drug Designer's Perspective**.
- Published in:
- Chemistry - A European Journal, 2022, v. 28, n. 56, p. 1, doi. 10.1002/chem.202201993
- Publication type:
- Article
Characterization of the designer drug bk-2C-B (2-amino-1-(bromodimethoxyphenyl) ethan-1-one) by gas chromatography/mass spectrometry without and with derivatization with 2,2,2-trichloroethyl chloroformate, liquid chromatography/high-resolution mass spectrometry, and nuclear magnetic resonance
- Published in:
- Rapid Communications in Mass Spectrometry: RCM, 2015, v. 29, n. 13, p. 1196, doi. 10.1002/rcm.7211
- By:
- Publication type:
- Article
Identification of designer drug 2C-E (4-ethyl-2, 5-dimethoxyphenethylamine) in urine following a drug overdose.
- Published in:
- Baylor University Medical Center Proceedings, 2013, v. 26, n. 1, p. 58, doi. 10.1080/08998280.2013.11928922
- By:
- Publication type:
- Article
Challenges of New Emerging Designer Drugs.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
The ketamine analog methoxetamine: a new designer drug to threaten military readiness.
- Published in:
- 2014
- By:
- Publication type:
- journal article
2C or Not 2C: Phenethylamine Designer Drug Review.
- Published in:
- Journal of Medical Toxicology, 2013, v. 9, n. 2, p. 172, doi. 10.1007/s13181-013-0295-x
- By:
- Publication type:
- Article
Educated Guesses and Other Ways to Address the Pharmacological Uncertainty of Designer Drugs.
- Published in:
- Contemporary Drug Problems, 2016, v. 43, n. 3, p. 277, doi. 10.1177/0091450916662164
- By:
- Publication type:
- Article
Synthetic Cannabinoids: A New Frontier of Designer Drugs.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
Development and Validation of a Novel All-Inclusive LC–MS-MS Designer Drug Method.
- Published in:
- Journal of Analytical Toxicology, 2019, v. 43, n. 3, p. 161, doi. 10.1093/jat/bky087
- By:
- Publication type:
- Article
ELISA Detection of 30 New Amphetamine Designer Drugs in Whole Blood, Urine and Oral Fluid using Neogen® "Amphetamine" and "Methamphetamine/MDMA" Kits.
- Published in:
- Journal of Analytical Toxicology, 2016, v. 40, n. 7, p. 492, doi. 10.1093/jat/bkw060
- By:
- Publication type:
- Article
Analysis of New Designer Drugs in Post-Mortem Blood Using High-Resolution Mass Spectrometry.
- Published in:
- Journal of Analytical Toxicology, 2015, v. 39, n. 3, p. 163, doi. 10.1093/jat/bku144
- By:
- Publication type:
- Article
Determination of Designer Drug Cross-Reactivity on Five Commercial Immunoassay Screening Kits.
- Published in:
- Journal of Analytical Toxicology, 2015, v. 39, n. 2, p. 144, doi. 10.1093/jat/bku133
- By:
- Publication type:
- Article
Screening of Stimulants Including Designer Drugs in Urine Using a Liquid Chromatography Tandem Mass Spectrometry System.
- Published in:
- Journal of Analytical Toxicology, 2013, v. 37, n. 2, p. 64, doi. 10.1093/jat/bks091
- By:
- Publication type:
- Article
In silico and in vitro metabolism studies support identification of designer drugs in human urine by liquid chromatography/quadrupole-time-of-flight mass spectrometry.
- Published in:
- Analytical & Bioanalytical Chemistry, 2013, v. 405, n. 21, p. 6697, doi. 10.1007/s00216-013-7137-1
- By:
- Publication type:
- Article
STRANGER THAN FICTION: Modern Designer Drugs and the Federal Controlled Substances Analogue Act.
- Published in:
- Arizona State Law Journal, 2015, v. 47, n. 2, p. 449
- By:
- Publication type:
- Article
Deconstructing Designer Drugs.
- Published in:
- Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 2, p. 167, doi. 10.1002/cpt.462
- By:
- Publication type:
- Article
Designer Drugs 2.0.
- Published in:
- Clinical Pharmacology & Therapeutics, 2017, v. 101, n. 2, p. 152, doi. 10.1002/cpt.575
- By:
- Publication type:
- Article
Stimulation of the Epithelial Na<sup>+</sup> Channel in Renal Principal Cells by Gs-Coupled Designer Receptors Exclusively Activated by Designer Drugs.
- Published in:
- Frontiers in Physiology, 2021, v. 12, p. 1, doi. 10.3389/fphys.2021.725782
- By:
- Publication type:
- Article
Oral Treatment of Erectile Dysfunction: From Herbal Remedies to Designer Drugs.
- Published in:
- Journal of Sex & Marital Therapy, 1998, v. 24, n. 2, p. 69, doi. 10.1080/00926239808404920
- By:
- Publication type:
- Article
Baths Salts, Spice, and Related Designer Drugs: The Science Behind the Headlines.
- Published in:
- Journal of Neuroscience, 2014, v. 34, n. 46, p. 15150, doi. 10.1523/JNEUROSCI.3223-14.2014
- By:
- Publication type:
- Article
Characterization of Hepatotoxicity Mechanisms Triggered by Designer Cathinone Drugs (β-Keto Amphetamines).
- Published in:
- Toxicological Sciences, 2016, v. 153, n. 1, p. 89, doi. 10.1093/toxsci/kfw105
- By:
- Publication type:
- Article
Keto Amphetamine Toxicity—Focus on the Redox Reactivity of the Cathinone Designer Drug Mephedrone.
- Published in:
- Toxicological Sciences, 2014, v. 141, n. 1, p. 120, doi. 10.1093/toxsci/kfu108
- By:
- Publication type:
- Article
NBOMe Designer Drugs Reported to Texas Forensic Laboratories.
- Published in:
- Texas Public Health Journal, 2016, v. 68, n. 1, p. 4
- By:
- Publication type:
- Article
'Crocodile' - new dangerous designer drug of abuse from the East.
- Published in:
- Clinical Toxicology (15563650), 2012, v. 50, n. 4, p. 269, doi. 10.3109/15563650.2012.660574
- By:
- Publication type:
- Article